Rare Histological Features of Endometrial Carcinoma: Malignant Mixed Müllerian Tumour with Corpus Cancer Syndrome — A Case Report

Main Article Content

Razia Sultana
Yashasvini Mishra
Shivani Bhadkariya

Abstract

Malignant mixed Müllerian tumour (MMMT) is an uncommon variant of endometrial carcinoma that carries a poor prognosis due to its aggressive nature. We present a case of a 59-year-old woman who presented to our outpatient department with persistent abnormal vaginal bleeding for two months. Following biopsy, the tumour was diagnosed as uterine carcinosarcoma. She underwent a total abdominal hysterectomy with bilateral salpingo-oophorectomy and bilateral pelvic lymph node dissection. Final histopathological examination revealed features consistent with MMMT (carcinoma component: 80%, sarcoma component: 20%). According to the International Federation of Gynaecology and Obstetrics (FIGO), the tumour was staged as IIIB. One month postoperatively, the patient remained healthy and symptom-free.

Downloads

Download data is not yet available.

Article Details

How to Cite
Sultana, R., Mishra, Y., & Bhadkariya, S. (2025). Rare Histological Features of Endometrial Carcinoma: Malignant Mixed Müllerian Tumour with Corpus Cancer Syndrome — A Case Report. Central India Journal of Medical Research, 4(03), 68–70. https://doi.org/10.58999/cijmr.v4i03.280
Section
Case Report

References

1. Nama N, Cason FD, Misra S, Hai S, Tucci V, Haq F, et al. Carcinosarcoma of the uterus: a study from the Surveillance Epidemiology and End Result (SEER) database. Cureus. 2020;12(9):e10283.

2. Pautier P, Genestie C, Rey A, Morice P, Roche B, Lhommé C, et al. Analysis of clinicopathologic prognostic factors for 157 uterine sarcomas and evaluation of a grading score validated for soft tissue sarcoma. Cancer. 2000;88(6):1425–31.

3. Bansal N, Herzog TJ, Seshan VE, Schiff PB, Burke WM, Cohen CJ, et al. Uterine carcinosarcomas and grade 3 endometrioid cancers: evidence for distinct tumour behaviour. Obstet Gynecol. 2008;112(1):64–70.

4. Gorai I, Yanagibashi T, Taki A, Udagawa K, Miyagi E, Nakazawa T, et al. Uterine carcinosarcoma is derived from a single stem cell: an in vitro study. Int J Cancer. 1997;72(5):821–7.

5. Wada H, Enomoto T, Fujita M, Yoshino K, Nakashima R, Kurachi H, et al. Molecular evidence that most but not all carcinosarcomas of the uterus are combination tumours. Cancer Res. 1997;57(23):5379–85.

6. De Jong RA, Nijman HW, Wijbrandi TF, Reyners AK, Boezen HM, Hollema H. Molecular markers and clinical behaviour of uterine carcinosarcomas: focus on the epithelial tumour component. Mod Pathol. 2011;24(10):1368–79.

7. Meseci E, Naki MM. Prognostic factors, survival outcomes, and surgical practices when dealing with uterine sarcomas: 8 years’ clinical experience. J Turk Ger Gynecol Assoc. 2019;20(3):154–64.

Similar Articles

1 2 > >> 

You may also start an advanced similarity search for this article.